145 related articles for article (PubMed ID: 19191562)
1. Antitumor psoropermum xanthones and sarcomelicope acridones: privileged structures implied in DNA alkylation.
Nguyen HT; Lallemand MC; Boutefnouchet S; Michel S; Tillequin F
J Nat Prod; 2009 Mar; 72(3):527-39. PubMed ID: 19191562
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cytotoxic activity, and mechanism of action of furo[2,3-c]acridin-6-one and benzo[b]furo[3,2-h]acridin-6-one analogues of psorospermin and acronycine.
Boutefnouchet S; Gaboriaud-Kolar N; Nguyen TM; Depauw S; David-Cordonnier MH; Pfeiffer B; Léonce S; Pierré A; Tillequin F; Lallemand MC; Michel S
J Med Chem; 2008 Nov; 51(22):7287-97. PubMed ID: 18947222
[TBL] [Abstract][Full Text] [Related]
3. Acronycine derivatives: a promising series of anticancer agents.
Nguyen QC; Nguyen TT; Yougnia R; Gaslonde T; Dufat H; Michel S; Tillequin F
Anticancer Agents Med Chem; 2009 Sep; 9(7):804-15. PubMed ID: 19594412
[TBL] [Abstract][Full Text] [Related]
4. Benzo[b]acronycine derivatives: a novel class of antitumor agents.
Michel S; Gaslonde T; Tillequin F
Eur J Med Chem; 2004 Aug; 39(8):649-55. PubMed ID: 15276298
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships in the acronycine and benzo[b]acronycine series: role of the pyran ring.
Do Q; Thi Mai HD; Gaslonde T; Pfeiffer B; Léonce S; Pierré A; Michel S; Tillequin F; Dufat H
Eur J Med Chem; 2008 Dec; 43(12):2677-87. PubMed ID: 18342404
[TBL] [Abstract][Full Text] [Related]
6. [From acronycine to benzo-[b]-acronycine derivatives: potent antitumor agents].
Koch M
Bull Acad Natl Med; 2007 Jan; 191(1):83-91; discussion 91-3. PubMed ID: 17645109
[TBL] [Abstract][Full Text] [Related]
7. [New antitumor agents in the acronycine series].
Tillequin F
Ann Pharm Fr; 2002 Jul; 60(4):246-52. PubMed ID: 12378151
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic activity of psorospermin and acronycine analogues in the 3-propyloxy-acridin-9(10H)-one and -benzo[b]acridin-125H-one series.
Boutefnouchet S; Minh NT; Putrus R; Pfeiffer B; Léonce S; Pierré A; Michel S; Tillequin F; Lallemand MC
Eur J Med Chem; 2010 Feb; 45(2):581-7. PubMed ID: 19926174
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxic activity, and DNA binding properties of antitumor cis-1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine cinnamoyl esters.
Do Q; Tian W; Yougnia R; Gaslonde T; Pfeiffer B; Pierré A; Léonce S; Kraus-Berthier L; David-Cordonnier MH; Depauw S; Lansiaux A; Mazinghien R; Koch M; Tillequin F; Michel S; Dufat H
Bioorg Med Chem; 2009 Mar; 17(5):1918-27. PubMed ID: 19217791
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships and mechanism of action of antitumor benzo[b]pyrano[3,2-h]acridin-7-one acronycine analogues.
Thi Mai HD; Gaslonde T; Michel S; Tillequin F; Koch M; Bongui JB; Elomri A; Seguin E; Pfeiffer B; Renard P; David-Cordonnier MH; Laine W; Bailly C; Kraus-Berthier L; Léonce S; Hickman JA; Pierré A
J Med Chem; 2003 Jul; 46(14):3072-82. PubMed ID: 12825945
[TBL] [Abstract][Full Text] [Related]
11. [Structure activity relationships and mechanism of action of antitumor benzo[b]acronycine antitumor agents].
Seguin E; Tillequin F
Ann Pharm Fr; 2005 Jan; 63(1):44-52. PubMed ID: 15803100
[TBL] [Abstract][Full Text] [Related]
12. Influence of the stereoisomeric position of the reactive acetate groups of the benzo[b]acronycine derivative S23906-1 on its DNA alkylation, helix-opening, cytotoxic, and antitumor activities.
Depauw S; Gaslonde T; Léonce S; Kraus-Berthier L; Laine W; Lenglet G; Chiaroni A; Pfeiffer B; Bailly C; Michel S; Tillequin F; Pierré A; David-Cordonnier MH
Mol Pharmacol; 2009 Dec; 76(6):1172-85. PubMed ID: 19752199
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxic activity of benzo[a]pyrano[3,2-h] and [2,3-i]xanthone analogues of psorospermine, acronycine, and benzo[a]acronycine.
Sittisombut C; Boutefnouchet S; Trinh Van-Dufat H; Tian W; Michel S; Koch M; Tillequin F; Pfeiffer B; Pierré A
Chem Pharm Bull (Tokyo); 2006 Aug; 54(8):1113-8. PubMed ID: 16880654
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of psorospermin/quinobenzoxazine hybrids as structurally novel antitumor agents.
Kim MY; Na Y; Vankayalapati H; Gleason-Guzman M; Hurley LH
J Med Chem; 2003 Jul; 46(14):2958-72. PubMed ID: 12825936
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and cytotoxic activity of benzo[a]acronycine and benzo[b]acronycine substituted on the A ring.
Gaslonde T; Covello F; Velazquez-Alonso L; Léonce S; Pierré A; Pfeiffer B; Michel S; Tillequin F
Eur J Med Chem; 2011 May; 46(5):1861-73. PubMed ID: 21411193
[TBL] [Abstract][Full Text] [Related]
16. Design of novel antitumor DNA alkylating agents: the benzacronycine series.
David-Cordonnier MH; Laine W; Gaslonde T; Michel S; Tillequin F; Koch M; Léonce S; Pierré A; Bailly C
Curr Med Chem Anticancer Agents; 2004 Mar; 4(2):83-92. PubMed ID: 15032716
[TBL] [Abstract][Full Text] [Related]
17. Conformationally restricted analogues of psorospermin: design, synthesis, and bioactivity of natural-product-related bisfuranoxanthones.
Heald RA; Dexheimer TS; Vankayalapati H; Siddiqui-Jain A; Szabo LZ; Gleason-Guzman MC; Hurley LH
J Med Chem; 2005 Apr; 48(8):2993-3004. PubMed ID: 15828838
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and cytotoxic and antitumor activity of 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diacid hemiesters and carbamates.
Doan Thi Mai H; Gaslonde T; Michel S; Koch M; Tillequin F; Pfeiffer B; Renard P; Kraus-Berthier L; Léonce S; Pierré A
Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):293-7. PubMed ID: 14993749
[TBL] [Abstract][Full Text] [Related]
19. Topoisomerase II site-directed alkylation of DNA by psorospermin and its effect on topoisomerase II-mediated DNA cleavage.
Kwok Y; Hurley LH
J Biol Chem; 1998 Dec; 273(49):33020-6. PubMed ID: 9830055
[TBL] [Abstract][Full Text] [Related]
20. [Acronycine revisited: development of benzo[b]acronycine antitumor agents].
Tillequin F; Koch M
Ann Pharm Fr; 2005 Jan; 63(1):35-43. PubMed ID: 15803099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
